Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Hsin Hsu

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.
Cancer Research|June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancerYi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Cancer Cell|November 22, 2016
Deubiquitination and Stabilization of PD-L1 by CSN5Seung-Oe Lim, Chia-Wei Li, Weiya Xia, et al.
Nature Medicine|January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Communications|November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.
Nature Communications|January 31, 2020
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.
Cancer Research|January 14, 2016
AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 DegradationChia-Wei Li, Weiya Xia, Seung-Oe Lim, et al.
American Journal of Cancer Research|May 11, 2023
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cellsLei Nie, Ying-Nai Wang, Jung-Mao Hsu, et al.
Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.
Cancer Cell|December 12, 2018
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei-Chih Lee, Yueh-Fu Fang, Hirohito Yamaguchi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.
Cancer Research|June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancerYi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Cancer Cell|November 22, 2016
Deubiquitination and Stabilization of PD-L1 by CSN5Seung-Oe Lim, Chia-Wei Li, Weiya Xia, et al.
Nature Medicine|January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Communications|November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.
Nature Communications|January 31, 2020
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.
Cancer Research|January 14, 2016
AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 DegradationChia-Wei Li, Weiya Xia, Seung-Oe Lim, et al.
American Journal of Cancer Research|May 11, 2023
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cellsLei Nie, Ying-Nai Wang, Jung-Mao Hsu, et al.
Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.
Cancer Cell|December 12, 2018
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei-Chih Lee, Yueh-Fu Fang, Hirohito Yamaguchi, et al.
Pageof 3